Stay updated on STK-012 in Solid Tumors with Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page.

Latest updates to the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page
- Check2 days agoChange DetectedThe page's revision history shows a new version, v3.5.3, added to the records. This reflects a small system update rather than substantive changes to study information.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new revision entry v3.5.2 was added to the history, replacing the previous v3.5.0 entry.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check45 days agoChange DetectedRecord History now shows per-version changes for Study Status and Contacts/Locations (Revision: v3.5.0, added 2026-03-17/18).SummaryDifference0.5%

- Check52 days agoChange DetectedA new revision entry v3.4.3 was added and the previous v3.4.2 was removed from the record history. This update affects revision tracking rather than study content.SummaryDifference0.1%

- Check81 days agoChange DetectedRevision: v3.4.2 was added to the history. The funding-lapse notice and the earlier revision note (v3.4.1) were removed.SummaryDifference0.7%

- Check88 days agoChange DetectedAdded a government funding notice and a new revision entry (v3.4.1) to the history, and removed the previous revision entry (v3.4.0).SummaryDifference0.7%

Stay in the know with updates to STK-012 in Solid Tumors with Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page.